Literature DB >> 18490443

Single-stranded oligonucleotides can inhibit cytokine production induced by human toll-like receptor 3.

C T Ranjith-Kumar1, K E Duffy, J L Jordan, A Eaton-Bassiri, Robert Vaughan, Scott A Hoose, Roberta J Lamb, R T Sarisky, C Cheng Kao.   

Abstract

Toll-like receptor 3 (TLR3) can signal the production of a suite of cytokines and chemokines in response to double-stranded RNA (dsRNA) ligands or the dsRNA mimic poly(I-C). Using a human embryonic kidney 293T cell line to express human TLR3, we determined that poly(I-C)-induced signal could be significantly inhibited by single-stranded DNAs (ssDNAs), but not ssRNA or dsDNA. The ssDNA molecules that down-modulated TLR3 signaling did not affect TLR4 and do not require the hypomethylated CpG motif found in TLR9 ligands. The degree of modulation can be altered by the length, base sequence, and modification state of the ssDNAs. An inhibitory ssDNA was found to colocalize with TLR3 in transfected cells and in a cell line that naturally expresses TLR3. The inhibitory ssDNAs can compete efficiently with dsRNA for binding purified TLR3 ectodomains in vitro, while noninhibitory nucleic acids do not. The ssDNAs also decrease the levels of several cytokines produced by the human bronchial epithelial cell line BEAS-2B and by human peripheral blood mononuclear cells in response to poly(I-C) stimulation of native TLR3. These activities indicate that ssDNAs could be used to regulate the inflammatory response through TLR3.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18490443      PMCID: PMC2447120          DOI: 10.1128/MCB.00308-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  40 in total

Review 1.  Expression and function of Toll-like receptors in T lymphocytes.

Authors:  Dieter Kabelitz
Journal:  Curr Opin Immunol       Date:  2006-11-28       Impact factor: 7.486

Review 2.  Toll-like receptors and innate immunity.

Authors:  Satoshi Uematsu; Shizuo Akira
Journal:  J Mol Med (Berl)       Date:  2006-09       Impact factor: 4.599

3.  Biochemical and functional analyses of the human Toll-like receptor 3 ectodomain.

Authors:  C T Ranjith-Kumar; William Miller; Jin Xiong; William K Russell; Roberta Lamb; Jonathan Santos; Karen E Duffy; Larissa Cleveland; Mary Park; Kanchan Bhardwaj; Zhaoxiang Wu; David H Russell; Robert T Sarisky; M Lamine Mbow; C Cheng Kao
Journal:  J Biol Chem       Date:  2007-01-05       Impact factor: 5.157

4.  MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists.

Authors:  Aranya Bagchi; Elizabeth A Herrup; H Shaw Warren; James Trigilio; Hae-Sook Shin; Catherine Valentine; Judith Hellman
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

5.  Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells.

Authors:  S Matsukura; F Kokubu; M Kurokawa; M Kawaguchi; K Ieki; H Kuga; M Odaka; S Suzuki; S Watanabe; H Takeuchi; T Kasama; M Adachi
Journal:  Clin Exp Allergy       Date:  2006-08       Impact factor: 5.018

6.  Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides.

Authors:  Marion Jurk; Andrea Kritzler; Bettina Schulte; Sibylle Tluk; Christian Schetter; Arthur M Krieg; Jörg Vollmer
Journal:  Eur J Immunol       Date:  2006-07       Impact factor: 5.532

Review 7.  Bacterial sepsis and chemokines.

Authors:  Makiko Kobayashi; Yasuhiro Tsuda; Tsuyoshi Yoshida; Dan Takeuchi; Tokuichiro Utsunomiya; Hitoshi Takahashi; Fujio Suzuki
Journal:  Curr Drug Targets       Date:  2006-01       Impact factor: 3.465

8.  Oligonucleotides suppress IL-8 in skin keratinocytes in vitro and offer anti-inflammatory properties in vivo.

Authors:  Annette Dorn; Ralf Joachim Ludwig; Andreas Bock; Diamant Thaci; Katja Hardt; Jurgen Bereiter-Hahn; Roland Kaufmann; August Bernd; Stefan Kippenberger
Journal:  J Invest Dermatol       Date:  2006-11-30       Impact factor: 8.551

9.  Nucleic acids exert a sequence-independent cooperative effect on sequence-dependent activation of Toll-like receptor 9.

Authors:  Jason Kindrachuk; Jean E Potter; Robert Brownlie; Andrew D Ficzycz; Philip J Griebel; Neeloffer Mookherjee; George K Mutwiri; Lorne A Babiuk; Scott Napper
Journal:  J Biol Chem       Date:  2007-03-13       Impact factor: 5.157

10.  Structural and functional analyses of the human Toll-like receptor 3. Role of glycosylation.

Authors:  Jingchuan Sun; Karen E Duffy; C T Ranjith-Kumar; Jin Xiong; Roberta J Lamb; Jon Santos; Hema Masarapu; Mark Cunningham; Andreas Holzenburg; Robert T Sarisky; M Lamine Mbow; Cheng Kao
Journal:  J Biol Chem       Date:  2006-02-16       Impact factor: 5.157

View more
  17 in total

Review 1.  Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases.

Authors:  Jing Li; Xiaohui Wang; Fengchun Zhang; Hang Yin
Journal:  Pharmacol Ther       Date:  2013-03-24       Impact factor: 12.310

2.  Toll-like receptor (TLR) 3 immune modulation by unformulated small interfering RNA or DNA and the role of CD14 (in TLR-mediated effects).

Authors:  Cordula Weber; Christian Müller; Anja Podszuweit; Carmen Montino; Jörg Vollmer; Alexandra Forsbach
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

3.  Novel drugs targeting Toll-like receptors for antiviral therapy.

Authors:  Mira C Patel; Kari Ann Shirey; Lioubov M Pletneva; Marina S Boukhvalova; Alfredo Garzino-Demo; Stefanie N Vogel; Jorge Cg Blanco
Journal:  Future Virol       Date:  2014-09       Impact factor: 1.831

4.  Raftlin is involved in the nucleocapture complex to induce poly(I:C)-mediated TLR3 activation.

Authors:  Ayako Watanabe; Megumi Tatematsu; Kazuko Saeki; Sachiko Shibata; Hiroaki Shime; Akihiko Yoshimura; Chikashi Obuse; Tsukasa Seya; Misako Matsumoto
Journal:  J Biol Chem       Date:  2011-01-25       Impact factor: 5.157

5.  Secretion of the human Toll-like receptor 3 ectodomain is affected by single nucleotide polymorphisms and regulated by Unc93b1.

Authors:  Rongsu Qi; Scott Hoose; Jessica Schreiter; Kirti V Sawant; Roberta Lamb; C T Ranjith-Kumar; Juliane Mills; Lani San Mateo; Jarrat L Jordan; C Cheng Kao
Journal:  J Biol Chem       Date:  2010-09-20       Impact factor: 5.157

6.  The human antimicrobial peptide LL-37, but not the mouse ortholog, mCRAMP, can stimulate signaling by poly(I:C) through a FPRL1-dependent pathway.

Authors:  Divyendu Singh; Rongsu Qi; Jarrat L Jordan; Lani San Mateo; C Cheng Kao
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

7.  Endosomal Toll-Like Receptors Mediate Enhancement of Interleukin-17A Production Triggered by Epstein-Barr Virus DNA in Mice.

Authors:  Marwa Shehab; Nour Sherri; Hadi Hussein; Noor Salloum; Elias A Rahal
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

8.  LL-37 peptide enhancement of signal transduction by Toll-like receptor 3 is regulated by pH: identification of a peptide antagonist of LL-37.

Authors:  Divyendu Singh; Robert Vaughan; C Cheng Kao
Journal:  J Biol Chem       Date:  2014-08-04       Impact factor: 5.157

9.  Green tea catechin, epigallocatechin gallate, suppresses signaling by the dsRNA innate immune receptor RIG-I.

Authors:  C T Ranjith-Kumar; Yvonne Lai; Robert T Sarisky; C Cheng Kao
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

10.  RNA binding by the brome mosaic virus capsid protein and the regulation of viral RNA accumulation.

Authors:  Guanghui Yi; Robert C Vaughan; Ian Yarbrough; S Dharmaiah; C Cheng Kao
Journal:  J Mol Biol       Date:  2009-05-27       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.